Login

Register

Login

Register

Gilead Sciences Nears Key Buy Level

Shares of Gilead Sciences (GILD) is pulling back after its recent surge. Since January, Gilead Sciences surged from below $57 to above $68. This massive upswing was off of multi-year lows as investors started to flood back to quality biotech names. With the stock currently pulling back, it is creating a key buy level. The pull back is known as bullish consolidation and likely will setup for the next big move higher. The buy level is a technical gap fill at $63.25. From this level, investors can expect another strong move higher to a potential high of $85.00.

Members of Gareth’s Verified Investing Alerts closed out a total of 206 swing trades in 2020 for a net gain of 1,507.67%. So far in January 2021, Gareth already banked a 10.44% winner on $PTON short, 13.57% on $QS long, 8.55% on $ICPT long, 14.35% on $FUBO long, 11.70% on PLUG short, 5.03% on JPM short and 14.97% on ICPT long. The total gain so far is 83.80% just in January. Members are crushing 2021!  Join now and get the exact entry/exit price alerts, stops and targets…LIVE. Get The Action NOW by Clicking HERE